Introduction Interactions of different hemoglobin variants with thalassemia alleles can result in various clinical phenotypes. HbE-β-thalassemia generally manifests with severe anemia where individuals exhibit β-thalassemia major with regular blood transfusions or β-thalassemia intermedia with periodic blood transfusions. This study presents a unique Malay family with three β-globin gene defects-HbE, Hb South Florida, and IVS1-1 (G→A). Materials and methods HbE activates a cryptic splice site that produces non-functional mRNAs. Hb South Florida is a rare β-hemoglobin variant, and its interactions with other β-thalassemia alleles have not been reported. IVS1-1 is a Mediterranean mutation that affects mRNA processing giving rise to β o -thalassemia. Results and discussion Fifteen mutations along the β-globin gene complex were analyzed using the amplification refractory mutation system. Hb South Florida was identified by direct sequencing using genomic DNA Conclusion The affected child with HbE/IVS1-1 produced a β-thalassemia major phenotype. Compound heterozygosity for Hb South Florida/IVS1-1 produced a β-thalassemia carrier phenotype in the mother.
Introduction
The genetic disorders of hemoglobin include the thalassemias and structural hemoglobin variants. The thalassemias are caused by specific mutations or deletions in the β-globin gene complex, which result in the absence or reduced production of one or more globin chains in hemoglobin. Structural hemoglobin variants are caused by amino acid substitutions in the globin chains, which lead to alterations in the stability and functional properties of hemoglobin. Both the thalassemias and hemoglobin variants are common in the East Asian populations of India, Thailand, Taiwan, China, and Malaysia [1, 23, 26] and is also reported in high frequencies in the Mediterranean region, north and central Africa, and in the Middle East [3, 25] .
The clinically important β-hemoglobin variants are HbS, HbC, and HbE. In the heterozygous states for HbS, HbC, and HbE, the patients are generally asymptomatic. Homozygosity for HbS results in sickle cell anemia and mild hemolytic anemia is presented with homozygosity for HbC and HbE. Interactions between two different hemoglobin variants can result in more severe problems. HbSC disease is characterized by a milder anemia than sickle cell anemia; however, health complications arise as the red blood cells are severely dehydrated, microcytic, and hypochromic [2] .
Thalassemia is a public health problem in Malaysia, and about 4.5% of the Malays and Chinese are heterozygous for β-thalassemia [11] . Individuals with β-thalassemia major are severely anemic and require blood transfusions throughout life. The condition arises with the inheritance of two β-globin gene mutations either in a compound heterozygous or homozygous state. Beta-thalassemia trait (minor) is usually asymptomatic and is associated with the inheritance of a single β-globin gene defect. Beta-thalassemia intermedia produce moderate anemia, and the majority of affected individuals do not require regular blood transfusions.
In addition to thalassemia, the structural hemoglobin variant HbE is also common in Malaysia with the ratio of HbE in the Malays to the Chinese of 10:1 [10] . Both HbE and β-thalassemia are present in the Malaysian Malays; compound heterozygosity for HbE-β-thalassemia is, thus, common in this ethnic group. Homozygote for HbE and HbE carriers (heterozygote) are asymptomatic with a mild form of thalassemia; however, compound heterozygosity for HbE-β-thalassemia manifest clinical phenotypes that vary from mild anemia to severe β-thalassemia major [5] . It is still not conclusive as to why different phenotypes are expressed, but the clinical severity of HbE-β-thalassemia has been reported to be dependent on a variety of factorsthe type of β-thalassemia allele (β + /β o ) involved, coinheritance of α-thalassemia, and co-inheritance of genetic factors that result in the production of HbF into adult life [9, 12] . Studies on the interaction of other hemoglobin variants with different β-thalassemia alleles have also shown variable clinical phenotypes [12] .
The presence of the severe forms of hemoglobin disorders poses a heavy load on blood transfusion and pediatric services, with the only "cure" being a successful bone marrow, cord blood, or stem cell transplant. A direct solution to alleviate this problem is the early identification of the disorder in affected couples at risk of producing a β-thalassemia major child.
Screening tests for thalassemia and Hb variants include routine peripheral blood counts, blood films, and red cell indices with hemoglobin analysis performed on blood samples with a mean cell volume (MCV) <80 fl and mean cell hemoglobin (MCH) <27 pg. Hemoglobin subtypes are quantified by high-performance liquid chromatography. When hematological tests suggest a β-globin gene defect, molecular studies are carried out to confirm the specific gene mutation(s) involved followed by genetic counseling and prenatal diagnosis for affected families.
This study presents a unique family with β-thalassemia defects composing of a β-globin gene mutation at intervening sequence1-1 (IVS1-1) (G→A) and two β-hemoglobin variants, HbE and Hb South Florida. Hb South Florida is a rare hemoglobin variant that involves an amino acid substitution of methionine for the NH 2 -terminal valine of the β-globin chain [4] . This is the first report of compound heterozygosity for Hb South Florida/IVS1-1 and HbE/IVS1-1 and the different clinical phenotypes presented.
Materials and methods

Case report
The child was reported to be well until development of frequent fever at 20 months of age. Thalassemia was suspected when the child also showed pallor and hepatosplenomegaly. Blood tests in a private hospital confirmed only HbE. She received her first blood transfusion at 24 months of age with a pre-transfusion Hb of 5.5 g/dl. At 4 years of age, she was admitted to the University Malaya Medical Center (UMMC) with severe anemia and hepatosplenomegaly.
Blood samples
Anti-coagulated peripheral blood samples (5 ml) in ethylenediamine tetra-acetic acid were collected from the child and parents. Nutritional anemia was checked using serum iron, serum ferritin, serum folate, and vitamin B 12 assays. Results of blood analysis for the child and her mother are presented in Table 1 . Routine peripheral blood counts and red cell indices were determined according to standard laboratory procedures. Peripheral blood films, HbH inclusion body detection, measurement of HbF, and hemoglobin electrophoresis were carried out. Blood was also sent for molecular analysis. Molecular studies on β-thalassemia in the UMMC have been approved by the Medical Ethics Committee of UMMC in accordance with the Declaration of Helsinki. Verbal and written consent was obtained from the parents prior to blood collection.
DNA amplification studies using the amplification refractory mutation system (ARMS)
The ARMS is a sensitive and specific technique used for the detection of DNA templates with single nucleotide mutations. ARMS allows direct detection of normal sequences and β-globin mutations in the β-globin gene complex. The principle of the ARMS is that the terminal 3′-nucleotide of a polymerase chain reaction primer must be allele specific for DNA amplification of a specific molecular weight product. DNA was extracted from the blood samples. Sixteen mutations in the β-globin gene complexinitiation codon for translation (T-G),
-654 (C-T), and poly A (A-G)-were characterized using an in-house-developed ARMS technique [22] . The primer sequences to detect the β-globin mutations were paired with common ARMS primers to amplify each β-mutation as a specific molecular weight product.
Direct sequencing using genomic DNA Direct sequencing was carried out using patient and mother's DNA to confirm the Mediterranean β-globin gene mutation at IVS1-1. The primers used to amplify a 904 base pair (bp) fragment were-B1: 5′-GCTTACCAAGC TGTGATTCCAA-3′ (forward) at nucleotide position −294 to −272 and primer B16: 5′-TCATTCGTCTGTTTCCCAT TCTAAAC-3′ (reverse) at position +609 to +574, both relative to the Cap site of the β-globin gene [21] . The specific fragment amplified consisted of the promoter region, exon 1, IVS1, exon 2, and the 5′ IVS2 regions of the β-globin gene.
Purification of the 904 bp product was carried out using High Pure PCR Purification Kit (Boehringer Mannheim). Direct sequencing was then carried out with primer B1 using the ABI PRISM Bigdye Terminator Cycle Sequencing Ready Reaction Kit (Perkin Elmer, Applied Biosystems Division, USA). The sequenced products were purified using ethanol/ sodium acetate precipitation and electrophoresed in the ABI PRISM 377 Sequencer. Direct sequencing was also carried out in reverse using primer B16 to confirm the β-globin gene mutation detected by forward genomic sequencing. Figure 1 shows the PCR products electrophoresed on a 1.5% agarose gel after DNA amplification using ARMS. The ARMS amplifies each β-gobin gene mutation as a distinct fragment with a specific molecular weight. HbE was amplified as a 458 bp fragment (lanes 2 and 3), and IVS1-1 (G→A) was amplified as a 281 bp fragment (lanes 4 and 5). The 861 bp internal control was simultaneously amplified with the β-globin mutations and confirms the success of the PCR reactions (lanes 1-5). A DNA blank where no DNA was added to the reaction tube was also included in each ARMS reaction (lane 6). Using the ARMS, HbE was confirmed in the father and the child (lanes 2 and 3) , and the β-gobin gene mutation at IVS1-1 was detected in the child and mother (lanes 4 and 5).
Results
Direct sequencing was carried out to confirm the IVS1-1 (G→A) globin gene mutation as it is not a common mutation in Asians. The sequencing results not only confirm the IVS1-1 mutation but also detected a rare hemoglobin variant, Hb South Florida, in the mother (Fig. 2) . Direct sequencing carried out using a reverse primer supported the results. The pedigree and genotypes of the family are shown in Fig. 1 . Thus, using ARMS and direct sequencing, heterozygous HbE was confirmed in the father, compound heterozygosity for Hb South Florida/ IVS1-1 was confirmed in the mother, and HbE/IVS1-1 was confirmed in the β-thalassemia major child.
Discussion
The rare hemoglobin variant, Hb South Florida, was first detected in a Caucasian family and has not been reported in any other individual since 1985 [14, 17] . The base substitution of GTG to ATG in codon 1 of the β-globin gene results in an elongated β-chain as a result of the retention of the initiator methionine on the mutant polypeptide. Hb South Florida makes up 40% of the total hemoglobin and cannot be detected by Hb electrophoresis as acetylation of the N-terminal methionine residue occurs less easily than in the other amino acids [20] . Hb South Florida does not cause any significant clinical problems in heterozygous individuals. In this study, the interaction of Hb South Florida with a β o -thalassemia allele, IVS1-1, produced a β-thalassemia carrier phenotype in the mother as observed by her hematological results ( Table 1) . The peripheral blood film of the mother showed hypochromic, microcytic cells with occasional target cells. In addition, she showed reduced MCV and MCH.
The mutation at IVS1-1 causes abnormal splicing of RNA due to the single G→A base pair substitution in the splice junction of the β-globin gene [24] . IVS1-1 (G→A) is a Mediterranean β-thalassemia mutation [16] and has been frequently reported in Italy [19] , Sicily [6] , in about 13% of Egyptian [7] , and 17.3% of Lebanese [27] β-thalassemia patients. Recent studies showed this mutation in β-thalassemia patients outside the Mediterranean region, for example in Germany [8] , Northern Ireland [14] , and Indonesia [15] . The Malays show a more heterogeneous pool of gene mutations compared with the other Malaysian ethnic groups (Chinese, Indians, and Orang Asli) [22] . The presence of IVS1-1(G→A) in this Malaysian Malay family may be a result of ancestral migration from countries bordering the Mediterranean Sea as the Malaysian Malays have ancestral links with Turkey, Persia, and the Middle East. This is further supported as IVS1-1(G→A) was also reported in β-thalassemia cases from the Aegean Region of Turkey [13, 18] . However, it appears more likely that the IVS1-1(G→A) β-globin gene mutation may have resulted from migration of Indonesians to Malaysia or intermarriages of Malaysians with Indonesians as this mutation has been reported to be present in Indonesian β-thalassemia individuals with a frequency of 1.7% [15] .
HbE and its interactions with β-thalassemia alleles have been commonly reported in Eastern parts of India, Southern China, and Southeast Asia [5, 9, 23] ; however, there are limited data of HbE in association with IVS1-1 (G→A). On admission, the child showed mild malar hyperplasia but with no frontal bossing and had hepatomegaly of 3 cm below the right costal margin. Blood transfusion was started and initially carried out every 3 months when her hemoglobin dropped to below 7 g/dl. Blood transfusions were subsequently increased to every 6 to 8 weeks when pre-transfusion hemoglobin ranged from 5.8 to 6.9 g/dl.
Compound heterozygosity for HbE/IVS1-1 in the child in this study produced a β-thalassemia major phenotype. The child will require blood transfusions throughout life to maintain a mean hemoglobin level of above 10 g/dl for normal growth and development and to prevent bone deformities and hepatosplenomegaly. In addition, iron chelation therapy will also be necessary for life to prevent iron loading due to iron accumulation from transfused blood and the increased iron absorption from the gastrointestinal tract.
The variable phenotypes observed in HbE-β-thalassemia can result from the inheritance of either a mild (β + ) or severe (β o ) β-thalassemia allele together with the HbE gene. The β-globin gene mutation at IVS1-1 (G→T) is common in Malaysia and Thailand compared with IVS1-1 (G→A) that has been more frequently observed in India and Sri Lanka [25] . Both cause β o -thalassemia as the mutations completely abolish β-globin chain production. Both HbE/IVS1-1 (G→T) and HbE/IVS1-1 (G→A) produce about 30-70% HbF. While HbE/IVS1-1 (G→T) produces hemoglobin of between 5 and 8 g/dl, HbE/IVS1-1 (G→A) does not differ much with hemoglobin production of between 4 and 8 g/dl.
Malaysia has a multi-racial population with the Malays and indigenous people (Orang Asli) comprising 65%, Chinese 26%, Indians 7.7%, and other minority groups making up the remaining 2% of the population. The mutations responsible for thalassemia and hemoglobin variants are specific for each region and ethnic group. Thalassemia and hemoglobin variants in Malaysia are rapidly identified with information of the patients' ethnic group and from hematological and clinical investigations. In our laboratory, molecular characterization and confirmation of hemoglobin disorders generally follow a routine protocol where common and rare β-gobin gene mutations specific to an ethnic group are first analyzed using ARMS. Direct sequencing using genomic DNA is then carried out when the β-globin gene mutations cannot be identified using ARMS. In a multi-racial population, many mutations contribute to the heterogeneity of defects responsible for thalassemia and hemoglobin variants. Pediatricians and genetic counselors need to be cautious in their diagnosis of hemoglobin disorders when molecular characterization has not been carried out and in particular to cases when clinical phenotypes do not match with hematology results.
